135 related articles for article (PubMed ID: 1378640)
21. Effect of thromboxane antagonists on prostaglandin regulation of platelet adenylate cyclase.
Ashby B
Second Messengers Phosphoproteins; 1988-1989; 12(5-6):241-50. PubMed ID: 2483174
[TBL] [Abstract][Full Text] [Related]
22. Regulation of prostacyclin and prostaglandin E(2) receptor mediated responses in adult rat dorsal root ganglion cells, in vitro.
Rowlands DK; Kao C; Wise H
Br J Pharmacol; 2001 May; 133(1):13-22. PubMed ID: 11325789
[TBL] [Abstract][Full Text] [Related]
23. Refractoriness of platelets to prostaglandins after infusion in rabbits.
Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
[TBL] [Abstract][Full Text] [Related]
24. The effect of low-density lipoproteins on the synthesis of cyclic nucleotides induced by prostacyclin in isolated platelets.
Bruckdorfer KR; Buckley S; Hassall DG
Biochem J; 1984 Oct; 223(1):189-96. PubMed ID: 6093767
[TBL] [Abstract][Full Text] [Related]
25. Prostacyclin-dependent cyclic AMP formation in endothelial cells.
Schröder H; Schrör K
Naunyn Schmiedebergs Arch Pharmacol; 1993 Jan; 347(1):101-4. PubMed ID: 7680437
[TBL] [Abstract][Full Text] [Related]
26. Competitive antagonism at thromboxane receptors in human platelets.
Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH
Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
[TBL] [Abstract][Full Text] [Related]
27. Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery.
Clapp LH; Finney P; Turcato S; Tran S; Rubin LJ; Tinker A
Am J Respir Cell Mol Biol; 2002 Feb; 26(2):194-201. PubMed ID: 11804870
[TBL] [Abstract][Full Text] [Related]
28. Prostacyclin receptor desensitization is a reversible phenomenon in human platelets.
Fisch A; Tobusch K; Veit K; Meyer J; Darius H
Circulation; 1997 Aug; 96(3):756-60. PubMed ID: 9264479
[TBL] [Abstract][Full Text] [Related]
29. The prostacyclin analogues, cicaprost and iloprost, increase cytosolic Ca2+ concentration in the human erythroleukemia cell line, HEL, via pertussis toxin-insensitive G-proteins.
Schwaner I; Seifert R; Schultz G
Eicosanoids; 1992; 5 Suppl():S10-2. PubMed ID: 1280455
[TBL] [Abstract][Full Text] [Related]
30. MaxiK channel-mediated relaxation of guinea-pig aorta following stimulation of IP receptor with beraprost via cyclic AMP-dependent and -independent mechanisms.
Yamaki F; Kaga M; Horinouchi T; Tanaka H; Koike K; Shigenobu K; Toro L; Tanaka Y
Naunyn Schmiedebergs Arch Pharmacol; 2001 Dec; 364(6):538-50. PubMed ID: 11770009
[TBL] [Abstract][Full Text] [Related]
31. High concentrations of exogenous arachidonate inhibit calcium mobilization in platelets by stimulation of adenylate cyclase.
Kowalska MA; Rao AK; Disa J
Biochem J; 1988 Jul; 253(1):255-62. PubMed ID: 2458717
[TBL] [Abstract][Full Text] [Related]
32. Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets.
Williams KA; Murphy W; Haslam RJ
Biochem J; 1987 May; 243(3):667-78. PubMed ID: 2444206
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
Haslam RJ; Davidson MM; Desjardins JV
Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
[TBL] [Abstract][Full Text] [Related]
34. The inhibitory effects of non-prostanoid prostacyclin mimetics on rat neutrophil function.
Wise H
Prostaglandins Leukot Essent Fatty Acids; 1996 May; 54(5):351-60. PubMed ID: 8832764
[TBL] [Abstract][Full Text] [Related]
35. Effects of prostacyclin analogs on the synthesis of tissue factor, tumor necrosis factor-alpha and interleukin-1 beta in human monocytic THP-1 cells.
Crutchley DJ; Conanan LB; Que BG
J Pharmacol Exp Ther; 1994 Oct; 271(1):446-51. PubMed ID: 7525928
[TBL] [Abstract][Full Text] [Related]
36. Affinity for [3H]iloprost binding sites and cAMP synthesis activity of a 3-oxa-methano prostaglandin I1 analog, SM-10906, in human platelets and endothelial cells.
Hiroi T; Maruyama K; Hattori K; Ohnuki T; Nagatomo T; Watanabe K; Yamamoto T; Hara Y
Jpn J Pharmacol; 1997 May; 74(1):37-43. PubMed ID: 9195295
[TBL] [Abstract][Full Text] [Related]
37. Functional relationship between cyclic AMP-dependent protein phosphorylation and platelet inhibition.
Siess W; Lapetina EG
Biochem J; 1990 Nov; 271(3):815-9. PubMed ID: 1700902
[TBL] [Abstract][Full Text] [Related]
38. TEI-9063, a stable and highly specific prostacyclin analogue for the prostacyclin receptor in mastocytoma P-815 cells.
Negishi M; Hashimoto H; Yatsunami K; Kurozumi S; Ichikawa A
Prostaglandins; 1991 Sep; 42(3):225-37. PubMed ID: 1723528
[TBL] [Abstract][Full Text] [Related]
39. Prostacyclin analogues differentially inhibit growth of distal and proximal human pulmonary artery smooth muscle cells.
Wharton J; Davie N; Upton PD; Yacoub MH; Polak JM; Morrell NW
Circulation; 2000 Dec; 102(25):3130-6. PubMed ID: 11120706
[TBL] [Abstract][Full Text] [Related]
40. Prostacyclin analogs suppress the synthesis of tumor necrosis factor-alpha in LPS-stimulated human peripheral blood mononuclear cells.
Eisenhut T; Sinha B; Gröttrup-Wolfers E; Semmler J; Siess W; Endres S
Immunopharmacology; 1993; 26(3):259-64. PubMed ID: 7507098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
